Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 157   

Articles published

AZN 4,954.55 -56.45 (-1.13%)
price chart
What does AstraZeneca plc's deal with Pfizer mean for shareholders?
More than a year after Pfizer approached AstraZeneca(LSE: AZN) about a potential merger, the US pharmaceutical giant has returned to do a deal with its UK counterpart.
Pfizer to Buy Antibiotics From AstraZeneca for $725 Million  Bloomberg
AstraZeneca to sell antibiotics business business to Pfizer Inc  Proactive Investors UK
Astrazeneca PLC (AZN) Stock Rating Reaffirmed by Beaufort Securities
Astrazeneca PLC logo Astrazeneca PLC (NYSE:AZN)'s stock had its “hold” rating reaffirmed by research analysts at Beaufort Securities in a research report issued on Friday.
Stock within Traders Observation: AstraZeneca PLC's (AZN)  Is stories
AstraZeneca plc (AZN) Given a GBX 4000 Price Target at Goldman Sachs Group Inc.  Community Financial News
AstraZeneca plc's (AZN) Hold Rating Reaffirmed at Shore Capital
JPMorgan Chase & Co. reissued a neutral rating and issued a GBX 4,900 ($64.38) price objective (up from GBX 4,800 ($63.07)) on shares of AstraZeneca plc in a research note on Monday, August 8th. Deutsche Bank AG reaffirmed a buy rating and issued a ...
AstraZeneca plc 4% Potential Decrease Indicated by JP Morgan Cazenove  DirectorsTalk Interviews
JP Morgan Cazenove Reiterated AstraZeneca PLC (LON:AZN) As 'Neutral'  FTSE News
Is it time to take profits on GlaxoSmithKline plc and AstraZeneca plc?
AstraZeneca(LSE: AZN) and GlaxoSmithKline(LSE: GSK) are two companies that have benefitted from this trend. Indeed, since Brexit shares in Astra have gained a staggering 32% and Glaxo's shares have gained 19.4%, both outperforming the wider FTSE ...
AstraZeneca plc (ADR)'s (AZN) Symbicort Gets New Life
AstraZeneca's plc (ADR) (NYSE:AZN) blockbuster drug Symbicort aerosol formulation showed comprehensive clinical results in relation to the two multi-center studies for the management and treatment of patients who have chronic obstructive pulmonary ...
Recent analysts Ratings: Astrazeneca PLC (NYSE:AZN)  News Oracle
Analysts Speculate on AstraZeneca plc (ADR) (NYSE:AZN)  Post Registrar
AstraZeneca's Alzheimer's drug fast-tracked by FDA
AstraZeneca PLC's (NYSE:AZN) Alzheimer's drug t is co-developing with Eli Lilly & Co (NYSE:LLY) has received fast-track designation from the US Food and Drug Administration (FDA).
Eli Lilly and Co and AstraZeneca plc Alzheimer's Drug Obtains Fast Track ...  Bidness ETC
Eli Lilly, AstraZeneca Get Fast-Track Status for Alzheimer's Drug  Wall Street Journal
Tech vs biotech: Is AstraZeneca plc or Apple Inc. the better buy?
Investing is all about looking to the future, investing not in what was successful in the past, but what will be successful in years to come.
AstraZeneca plc (ADR): What Are the Future Prospects?  Business Finance News
Astrazeneca PLC's (AZN) Hold Rating Reiterated at Shore Capital  The Cerbat Gem
AstraZeneca plc (ADR) (NYSE:AZN) Cope with the Future Challenges?
AstraZeneca's plc (ADR) (NYSE:AZN) is increasing its pace on multiple aspects to enhance its revenue in order to compete with the launching of generics and biosimilars in different therapeutic markets.
Analysts Ratings: Astrazeneca PLC (NYSE:AZN) , Cempra, Inc. (NASDAQ:CEMP)  Is stories
New Broker Ratings For Astrazeneca PLC (NYSE:AZN)  FTSE News
AstraZeneca plc (ADR) (AZN): Double Success in Oncology Portfolio Could Prove ...
AstraZeneca plc (ADR) (NYSE:AZN) has announced mutual collaboration with Rpositive, a Cambridge software firm, for the research and development of oncology molecules to treat different categories.
Is AstraZeneca A Buy After Opdivo Failure?  Seeking Alpha
Generics hound AstraZeneca despite Brilinta star turn
AstraZeneca's (LON:AZN) profits and sales both fell as patent expiries and heavy restructuring took their toll on the UK pharma's first half.
AstraZeneca swings to loss, missing forecasts  MarketWatch
AstraZeneca's Earnings Meet Estimates as New Drug Sales Rose  Bloomberg